Statins and PCSK9 inhibitors: A new lipid-lowering therapy

Title
Statins and PCSK9 inhibitors: A new lipid-lowering therapy
Authors
Keywords
Alirocumab, Evolocumab, PCSK9 inhibitors, Low-density lipoprotein, Major adverse cardiovascular effects, Guidelines
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 878, Issue -, Pages 173114
Publisher
Elsevier BV
Online
2020-04-15
DOI
10.1016/j.ejphar.2020.173114

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started